Related Experiment Videos
Kawasaki disease: an overview
Georgia S Pinna1, Dimitris A Kafetzis, Orestis I Tselkas
1Department of Microbiology, Evangelismos General Hospital, Athens, Greece.
Insights
Kawasaki disease, a childhood vasculitis, requires better diagnostics due to increasing frequency. This review summarizes known features and latest findings on its causes and treatments.
Area of Science:
- Pediatric rheumatology
- Immunology
- Vascular biology
Background:
- Kawasaki disease is an acute, self-limited childhood vasculitis with increasing incidence.
- Its etiology remains largely unknown, though infectious and genetic factors are implicated.
- It is a leading cause of acquired heart disease in children.
Purpose of the Study:
- To provide a comprehensive overview of Kawasaki disease.
- To highlight recent advancements in its diagnosis and treatment.
- To synthesize current knowledge on epidemiology, etiology, pathology, and sequelae.
Main Methods:
- Literature review of historical and recent publications.
- Synthesis of evidence on diagnostic markers and therapeutic strategies.
- Evaluation of genetic influences and long-term outcomes.
Main Results:
- Inflammatory markers like CCL2 and CCXCL10 are relevant for diagnosis and pathology.
- Intravenous immunoglobulin is the primary therapy, with alternatives for refractory cases.
- Potential etiological factors include viruses, bacterial superantigens, and genetic polymorphisms.
Conclusions:
- Understanding Kawasaki disease requires integrating historical, epidemiological, etiological, and genetic data.
- Contemporary diagnostic techniques and therapeutic approaches are continually evolving.
- Further research is crucial for improving outcomes and preventing long-term sequelae.
Purpose Of Review:
Kawasaki disease is an acute, self-limited vasculitis of childhood. The increasing frequency of the disease as well as the deficiency of specific diagnostic means renders its diagnosis and treatment an area of intense investigation. The purpose of this review is to summarize all the known features of Kawasaki disease and also give an insight to the latest findings.
Recent Findings:
Kawasaki disease is one of the leading causes of acquired heart disease in children while its cause remains essentially unknown. Viruses, bacterial conventional as well as superantigens, and genetic polymorphisms have been implicated in the etiology of the disease. Markers of inflammation, such as CCL2 and CCXCL10, contribute to the pathology and the diagnosis of Kawasaki disease. Intravenous administration of immunoglobulin remains the mainstay of therapy for Kawasaki disease. Nevertheless, forms of the disease refractory to intravenous administration of immunoglobulin therapy may respond to aspirin, corticosteroids, cyclophosphamide, and/or plasmapheresis.
Summary:
The present review covers evidence regarding the history of Kawasaki disease, the epidemiology, etiology, pathology, genetic influences, and long-term sequela. It also includes an evaluation of contemporary diagnostic techniques and optimal therapeutic approaches with an emphasis on recent publications.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Graves Disease II: Pathophysiology
Nephrotic Syndrome I : Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Graves' Disease I: Introduction